# Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

> **NCT01699867** · — · COMPLETED · sponsor: **Diagnostic Photonics, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Optical coherence tomography

## Key facts

- **NCT ID:** NCT01699867
- **Lead sponsor:** Diagnostic Photonics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2013-05
- **Final completion:** 2014-04
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2015-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01699867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01699867, "Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01699867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*